Jane Street’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.16M Sell
101,934
-198,966
-66% -$2.16M ﹤0.01% 6200
2025
Q4
$3.86M Buy
300,900
+201,434
+203% +$2.49M ﹤0.01% 3638
2025
Q3
$1.11M Buy
99,466
+31,137
+46% +$301K ﹤0.01% 6097
2025
Q2
$678K Buy
68,329
+21,526
+46% +$211K ﹤0.01% 6369
2025
Q1
$439K Buy
46,803
+34,054
+267% +$358K ﹤0.01% 7115
2024
Q4
$117K Sell
12,749
-27,593
-68% -$203K ﹤0.01% 8704
2024
Q3
$314K Buy
40,342
+1,026
+3% +$7.41K ﹤0.01% 7950
2024
Q2
$238K Sell
39,316
-5,287
-12% -$32.6K ﹤0.01% 8147
2024
Q1
$262K Buy
44,603
+5,998
+16% +$35.6K ﹤0.01% 7761
2023
Q4
$303K Sell
38,605
-25,168
-39% -$175K ﹤0.01% 7589
2023
Q3
$466K Buy
63,773
+4,861
+8% +$40.4K ﹤0.01% 6397
2023
Q2
$614K Buy
58,912
+10,119
+21% +$97.4K ﹤0.01% 6002
2023
Q1
$505K Buy
+48,793
New +$625K ﹤0.01% 6301
2022
Q4
Sell
-10,062
Closed -$206K 9078
2022
Q3
$206K Buy
+10,062
New +$221K ﹤0.01% 8134
2021
Q4
Sell
-18,140
Closed -$471K 9998
2021
Q3
$471K Buy
18,140
+8,463
+87% +$226K ﹤0.01% 7386
2021
Q2
$263K Buy
+9,677
New +$236K ﹤0.01% 8380

Other funds holding ANGO

Jane Street's ANGO Position: Q1 2026 in Review

Jane Street reduced its AngioDynamics (ANGO) stake by 66% in Q1 2026, selling an estimated $2.16M and leaving 101,934 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #6200.

Jane Street first reported a position in ANGO in Q2 2021 and has held it in 16 quarters since. The position peaked at $3.86M in Q4 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Jane Street held 101,934 shares of AngioDynamics worth $1.16M as of Q1 2026.
  • Jane Street sold 198,966 AngioDynamics shares in Q1 2026, an estimated $2.16M.
  • AngioDynamics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #6200 holding.
  • Jane Street first reported a position in AngioDynamics in Q2 2021 and has held it in 16 quarters since.
  • Jane Street's AngioDynamics position peaked at $3.86M in Q4 2025.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.